Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.

Biological psychiatry - 1 Nov 2003

Perlis Roy H, Mischoulon David, Smoller Jordan W, Wan Yu-Jui Yvonne, Lamon-Fava Stefania, Lin Keh-Ming, Rosenbaum Jerrold F, Fava Maurizio

Abstract excerpt

BACKGROUND: The short (S) allele of the serotonin transporter gene-linked polymorphic region (5HTTLPR) has been associated with poorer antidepressant response in major depressive disorder (MDD) and with antidepressant-induced mania. This study investigated a possible association with treatment-emergent insomnia or agitation. METHODS: Thirty-six outpatients with MDD were genotyped at 5HTTLPR and treated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluoxetine

Share to Membrane Glycoproteins

Share to Membrane Transport Proteins

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Share to Sleep Initiation and Maintenance Disorders

Source

Identifiers

PMID: 14573314
DOI: 10.1016/s0006-3223(03)00424-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.PMID 14573314Read ↗

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.Semantic proximity Read ↗

Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic EvidenceSemantic proximity Read ↗

Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.Semantic proximity Read ↗

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.Semantic proximity Read ↗

Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.Semantic proximity Read ↗

Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders.Semantic proximity Read ↗

Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.Semantic proximity Read ↗

Pharmacogenetics and the serotonin transporter in late-life depressionSemantic proximity Read ↗

Association between a serotonin transporter length polymorphism and primary insomnia.Semantic proximity Read ↗

Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.Semantic proximity Read ↗

Clinical Implications of Genetic Variation in the Serotonin Transporter Promoter RegionSemantic proximity Read ↗

Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.